F-star Therapeutics, Inc. Stock
Equities
FSTX
US30315R1077
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20-11-19 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Trish Hurley
LAW | General Counsel | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20-11-19 |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |